MedTech 101 Beating Depression with Wearable Headset Technology with Erin Lee
In this episode of the MedTech 101 podcast, host Rodney Moses sits down with Erin Lee, CEO of Flow Neuroscience, to talk about how technology is changing the way we treat mental health.
Erin shares the story behind Flow’s groundbreaking device that uses gentle brain stimulation to treat depression, without relying on traditional antidepressants. Together, they discuss the challenges of drug-based therapies and Flow’s mission to make mental health treatment more effective, affordable, and accessible.
Erin also opens up about her unconventional journey into medtech, from her time at leading tech firms to her eye-opening experience at Babylon Health, which shaped her vision for digital health innovation.
The conversation dives into how Flow operates as a Scandinavian company with a global footprint, spanning the UK, EU, and now expanding into the U.S. market. Erin explains the regulatory hurdles they face, how they navigate them, and what it takes to bring such a device to different regions.
She also talks about Flow’s wearable headset — a clinically proven, non-drug treatment that uses targeted electrical stimulation to improve mood. Finally, Erin reflects on the future of mental health care, where AI and medtech could work together to deliver more personalized and accessible treatments for people everywhere.
Timestamp
00:00 Revolutionizing Depression Treatment Without Antidepressants
01:44 Erin Lee's Unconventional Journey to Leading Flow Neuroscience
06:07 Innovative Headset Offers Drug-Free Depression Treatment
12:17 Challenges and Strategies in Medical Device Market Approvals
15:53 Challenges in Introducing Innovative Medical Devices to the Market
22:41 The Future of Personalized Brain Stimulation for Depression Treatment
29:31 Erin Lee Discusses Neuroscience and Upcoming Device Launch
Follow or Connect with Rodney Moses:
Instagram | LinkedIn | YouTube |
Donations
Patreon | PayPal